Jump to navigation
Mobile menu button
About
Partner Centers
People
Project ECHO for ILD
2022-2023 Curriculum
Idiopathic Pulmonary Fibrosis: A Diagnostic Approach
Shifting Paradigms of IPF Pathogenesis
Treatments for Idiopathic Pulmonary Fibrosis
Overview of Autoimmune ILD
Scleroderma-Associated ILD: Clinical Manifestations and Diagnosis
Idiopathic Pulmonary Fibrosis: Natural History and Survival
Myositis-Associated ILD: Clinical Manifestations and Diagnosis
Lung Biopsy in the Diagnosis of Fibrotic ILD
Sarcoidosis: Overview, Diagnosis and Monitoring
Rethinking Classification Criteria for Connective Tissue Diseases
Post-acute Sequelae of COVID-19 (PASC)
Acute Exacerbations of ILD
Scleroderma-Associated ILD: Treatment Approaches and Challenges
Myositis-Associated ILD: Treatment Approaches and Challenges
Pulmonary Hypertension Associated with ILD
More Than Meds: Nonpharmacologic Treatments for ILD
Hypersensitivity Pneumonitis: Approach and Challenges
Lung Transplant for ILD: When to Refer and What to Expect
Sarcoidosis: Beyond First Line Therapy
Genetics and the Development of Pulmonary Fibrosis
Hypersensitivity Pneumonitis: Treatment Approach and Challenges
HRCT Patterns and Pitfalls: Approach to Fibrotic Lung Disease
Common Comorbidities of ILD
Quality of Life and ILD: Palliative Care Along the Trajectory of Illness
2024-2025 Curriculum
Rheumatoid Arthritis-Associated ILD
Shifting Paradigms of IPF Pathogenesis
HRCT Patterns and Pitfalls: Approach to Fibrotic Lung Disease
Emerging Treatments for Pulmonary Fibrosis and Active Clinical Trials
Lung Cancer in Patients with ILD: Diagnostic and Management Considerations
Where's the Lung? Rethinking Classification Criteria for Connective Tissue Diseases
Myositis-Associated ILD: Clinical Manifestations and Diagnosis
A Guide to Immunosuppression
Lung Biopsy in the Diagnosis of ILD
Hypersensitivity Pneumonitis: Diagnostic Approach and Challenges
Pulmonary Manifestations of ANCA Vasculitis
Acute Exacerbations of ILD
Scleroderma-Associated ILD: Treatment Approaches and Challenges
Pulmonary Complications of Immunotherapy
Post-acute Sequelae of COVID-19 (PASC): “Long-haulers” and Pulmonary Disease
Hypersensitivity Pneumonitis: Update on Treatment Approaches
Pulmonary Hypertension Associated with ILD: Diagnosis and Management
Occupational Lung Disease
Myositis-Associated ILD: Treatment Approaches and Challenges
Lung Transplant for ILD: When to Refer and What to Expect
Obliterative Bronchiolitis
Sarcoidosis: Conventional and Evolving Treatments
Quality of Life and ILD: The Role of Palliative Care
Genetics and the Development of Pulmonary Fibrosis
Common Comorbidities of ILD
Project ECHO for ILD
Registration
Unsubscribe from Project ECHO for ILD
Virtual Meetings
Air Filtration
Air Pollution and Interstitial Lung Disease
Airway Clearance
Anesthesia for People With Interstitial Lung Disease
Art Therapy in Chronic Illness
Cough in ILD: Its Causes and Management
Eight Active Ingredients of Tai Chi
Eight Active Ingredients of Tai Chi
Gastroesophageal Reflux Disease (GERD) and ILD
Hypersensitivity Pneumonitis
Immunomodulatory Agents in the Treatment of ILD
Implementing Energy Conservation Strategies
Interstitial Lung Disease: The Journey to Diagnosis and Treatment
Living Better with ILD
Lung Transplant: Eligibility and Evaluation
Monthly Oxygen Therapy Series: Is It Time to Use Oxygen?
Monthly Oxygen Therapy Series: Portable Oxygen Concentrators and Travel
Monthly Palliative Care Series: Palliative Care and QoL in ILD
Nutritional Considerations for ILD
Pulmonary Hypertension: Diagnosis and Management
Sarcoidosis: Is There Better Treatment?
The Lived Experience Series: Financial and Tax Planning
Understanding Autoimmune-Related ILD
Unsubscribe from our Mailing Lists
Updates on Clinical Research for IPF and Other Forms of ILD (2023)
Updates on Clinical Research for IPF and Other Forms of ILD
Resources
Aspirational Patient Journey
Aspirational Patient Journey
Basics of ILDs
Basics of IPF
Blog
Genetics of Familial Idiopathic Interstitial Pneumonia
IPF Patient Journey
Early Symptoms
Delayed Diagnosis
IPF Diagnosis
Pharmacologic Treatments
Making Sense of the Illness
Oxygen Therapy
Pulmonary Rehabilitation
Acute Exacerbations
Lifestyle Changes
Palliative Care
Hospice Care
Lung Transplant
IPF and PF-ILD Clinical Trials
Monitoring Disease Progression in Idiopathic Pulmonary Fibrosis
Patient Symposium
Peer To Peer Support
Phase IV IPF Clinical Trials
Pulmonary Function Testing
Starting Oxygen Therapy
Support Groups
Webinars
Clinical Trials
PCRC Patient Registry
BMS-986278-IPF
BMS-986278-PPF
Bexotegrast-IPF
DWN12088-IPF
EFZO-FIT
FIBRONEER-IPF
FIBRONEER-PF-ILD
Inhaled Treprostinil Clinical Trial
PRECISIONS Trial
Home
Contact
Support
COVID-19
Events
Tai Chi
ILD Centers in the USA
Pulmonary Rehab Programs
Search
Login
You are here
Home
›
Virtual Meetings
›
Eight Active Ingredients of Tai Chi
Thursday, October 5, 11:00 am EDT, 2023